[EN] HALOGENATED CHOLESTEROL ANALOGUES AND METHODS OF MAKING AND USING SAME<br/>[FR] ANALOGUES HALOGÉNÉS DU CHOLESTÉROL ET LEURS PROCÉDÉS DE PRÉPARATION ET LEURS MÉTHODES D'UTILISATION
申请人:UNIV MICHIGAN REGENTS
公开号:WO2020069267A1
公开(公告)日:2020-04-02
Provided herein are halogenated cholesterol analogues, including methods of making and using the same. Also provided are methods of making radiolabeled cholesterol analogues including admixing an epoxide with a fluorine-18 source under conditions to form a radiofluorinated cholesterol analogue.
[EN] FOSFLUCONAZOLE DERIVATIVES, SYNTHESIS, AND USE IN LONG ACTING FORMULATIONS<br/>[FR] DÉRIVÉS DE FOSFLUCONAZOLE, SYNTHÈSE, ET UTILISATION DANS DES FORMULATIONS À LONGUE DURÉE D'ACTION
申请人:SEPS PHARMA N V
公开号:WO2010105910A1
公开(公告)日:2010-09-23
The invention relates to a compound of formula (I) and the salts, N-oxides, quaternary amines, and stereoisomers thereof, wherein R1 to R8 are as defined in the claims. The invention further relates to intermediates and methods for the preparation of the compounds of formula (I). The invention also relates to the compounds of formula (I) for use as a medicament, particularly for the prevention or treatment of fungal infections.
Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
申请人:Gonnissen Yves
公开号:US20120172336A2
公开(公告)日:2012-07-05
The invention relates to a compound of formula (1) and the salts, N-oxides, quaternary amines, and stereoisomers thereof, wherein R
1
to R
2
are as defined in the claims. The invention further relates to intermediates and methods for the preparation of the compounds of formula (I). The invention also relates to the compounds of formula (I) for use as a medicament, particularly for the prevention or treatment of fungal infections.
Halogenated Cholesterol Analogues and Methods of Making and Using Same
申请人:THE REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:US20210355154A1
公开(公告)日:2021-11-18
Provided herein are halogenated cholesterol analogues, including methods of making and using the same. Also provided are methods of making radiolabeled cholesterol analogues including admixing an epoxide with a fluorine-18 source under conditions to form a radiofluorinated cholesterol analogue.